Statin Use and Self-Reported Hindering Muscle Complaints in Older Persons: A Population Based Study

Effectiveness and cost-effectiveness of a proactive, goal-oriented, integrated care model in general practice for older people. A cluster randomised controlled trial: Integrated Systematic Care for older People—the ISCOPE study

(2016) Jeanet Blom et al.   AGE AND AGEING

Statin-associated muscle symptoms: impact on statin therapy—European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management

(2015) Erik S. Stroes et al.   EUROPEAN HEART JOURNAL

Self-Reported Hindering Health Complaints of Community-Dwelling Older Persons: A Cross-Sectional Study

(2015) Sophie C. E. van Blijswijk et al.   PLoS One

Aggressive Lipid Management in Very Elderly Adults: Less Is More

(2014) Michael W. Rich   JOURNAL OF THE AMERICAN GERIATRICS SOCIETY

What proportion of symptomatic side effects in patients taking statins are genuinely caused by the drug? Systematic review of randomized placebo-controlled trials to aid individual patient choice

(2014) Judith A Finegold et al.   European Journal of Preventive Cardiology

Narrative Review: Statin-Related Myopathy

(2013) Tisha R. Joy   ANNALS OF INTERNAL MEDICINE

Discontinuation of Statins in Routine Care Settings

(2013) Huabing Zhang et al.   ANNALS OF INTERNAL MEDICINE

Adherence to cardiovascular therapy: a meta-analysis of prevalence and clinical consequences

(2013) Rajiv Chowdhury et al.   EUROPEAN HEART JOURNAL

2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults

(2013) Neil J. Stone et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Should people at low risk of cardiovascular disease take a statin?

(2013) J. D. Abramson et al.   BMJ-British Medical Journal

Effect of Statins on Skeletal Muscle Function

(2012) Beth A. Parker et al.   CIRCULATION

European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts) * Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR)

(2012) et al.   EUROPEAN HEART JOURNAL

Nocebo Effects, Patient-Clinician Communication, and Therapeutic Outcomes

(2012) Luana Colloca et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Understanding Statin Use in America and Gaps in Patient Education (USAGE): An internet-based survey of 10,138 current and former statin users

(2012) Jerome D. Cohen et al.   Journal of Clinical Lipidology

Discontinuation of statin therapy due to muscular side effects: A survey in real life

(2012) D. Rosenbaum et al.   NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES

Lipid-lowering treatment to the end? A review of observational studies and RCTs on cholesterol and mortality in 80+-year olds

(2010) L. K. Petersen et al.   AGE AND AGEING

Statin-Associated Muscle-Related Adverse Effects: A Case Series of 354 Patients

(2010) Stephanie Cham et al.   PHARMACOTHERAPY

Management of Hyperlipidemia in Older Adults

(2009) Karen P. Alexander et al.   JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS

Long-term persistence with statin treatment in a not-for-profit health maintenance organization: A population-based retrospective cohort study in Israel

(2008) Gabriel Chodick et al.   CLINICAL THERAPEUTICS